AR012849A1 - Composicion farmaceutica antivirica. - Google Patents
Composicion farmaceutica antivirica.Info
- Publication number
- AR012849A1 AR012849A1 ARP980102218A ARP980102218A AR012849A1 AR 012849 A1 AR012849 A1 AR 012849A1 AR P980102218 A ARP980102218 A AR P980102218A AR P980102218 A ARP980102218 A AR P980102218A AR 012849 A1 AR012849 A1 AR 012849A1
- Authority
- AR
- Argentina
- Prior art keywords
- lysozyme
- composition
- protein
- pharmaceutical composition
- antivirica
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 235000010335 lysozyme Nutrition 0.000 abstract 7
- 108010014251 Muramidase Proteins 0.000 abstract 5
- 102000016943 Muramidase Human genes 0.000 abstract 5
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 5
- 229960000274 lysozyme Drugs 0.000 abstract 5
- 239000004325 lysozyme Substances 0.000 abstract 5
- 241000287828 Gallus gallus Species 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 235000018102 proteins Nutrition 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 abstract 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 abstract 1
- 229960004949 glycyrrhizic acid Drugs 0.000 abstract 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 abstract 1
- 239000001685 glycyrrhizic acid Substances 0.000 abstract 1
- 235000019410 glycyrrhizin Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000021242 lactoferrin Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001119A IT1291366B1 (it) | 1997-05-14 | 1997-05-14 | Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012849A1 true AR012849A1 (es) | 2000-11-22 |
Family
ID=11377123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102218A AR012849A1 (es) | 1997-05-14 | 1998-05-13 | Composicion farmaceutica antivirica. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6329339B1 (instruction) |
| EP (1) | EP0980254B1 (instruction) |
| JP (2) | JP2001525814A (instruction) |
| KR (1) | KR100592193B1 (instruction) |
| CN (1) | CN1114447C (instruction) |
| AR (1) | AR012849A1 (instruction) |
| AT (1) | ATE212232T1 (instruction) |
| AU (1) | AU740944B2 (instruction) |
| BG (1) | BG64748B1 (instruction) |
| CA (1) | CA2289550A1 (instruction) |
| CZ (1) | CZ291932B6 (instruction) |
| DE (1) | DE69803565T2 (instruction) |
| DK (1) | DK0980254T3 (instruction) |
| EA (1) | EA003126B1 (instruction) |
| ES (1) | ES2170501T3 (instruction) |
| GE (1) | GEP20022672B (instruction) |
| HU (1) | HU224956B1 (instruction) |
| IL (2) | IL132651A0 (instruction) |
| IT (1) | IT1291366B1 (instruction) |
| PL (1) | PL189218B1 (instruction) |
| PT (1) | PT980254E (instruction) |
| SK (1) | SK283584B6 (instruction) |
| TR (1) | TR199902730T2 (instruction) |
| UA (1) | UA63955C2 (instruction) |
| WO (1) | WO1998051334A1 (instruction) |
| ZA (1) | ZA983917B (instruction) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US7151082B2 (en) * | 1999-02-11 | 2006-12-19 | The Feinstein Institute For Medical Research | Antagonists of HMG1 for treating inflammatory conditions |
| US7304034B2 (en) * | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
| WO2003088914A2 (en) * | 2002-04-18 | 2003-10-30 | The University Of Iowa Research Foundation | Methods of inhibiting and treating bacterial biofilms by metal chelators |
| US7696169B2 (en) * | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| CN1878793A (zh) * | 2003-09-11 | 2006-12-13 | 鉴定医疗有限公司 | 拮抗hmgb1的单克隆抗体 |
| WO2007011606A2 (en) * | 2005-07-18 | 2007-01-25 | Critical Therapeutics, Inc. | USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS |
| US20080311122A1 (en) * | 2005-11-28 | 2008-12-18 | Medimmune, Llc | Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof |
| IT1391170B1 (it) * | 2008-08-07 | 2011-11-18 | D M G Italia S R L | Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale |
| WO2012026928A1 (en) * | 2010-08-25 | 2012-03-01 | Diacarta Llc | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| US9416151B2 (en) | 2010-08-25 | 2016-08-16 | Lurong ZHANG | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| US20170049863A1 (en) * | 2014-02-21 | 2017-02-23 | National University Corporation Tokyo University Of Marine Science And Technology | Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes |
| EP3419629A4 (en) * | 2016-02-25 | 2019-10-30 | Applied Biological Laboratories, Inc. | COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES |
| CN109022351B (zh) * | 2018-09-28 | 2021-10-19 | 广州奇龙生物科技有限公司 | 重组人溶菌酶的新应用 |
| CN117898418A (zh) * | 2020-04-27 | 2024-04-19 | 湘北威尔曼制药股份有限公司 | 一种对新冠病毒损伤有辅助保护作用的食物及其应用 |
| CN112135625B (zh) * | 2020-04-27 | 2021-07-06 | 广州新创忆药物临床研究有限公司 | 一种预防或治疗covid-19新冠肺炎的药物及其应用 |
| JP7399976B2 (ja) * | 2020-04-27 | 2023-12-18 | 広州新創憶薬物臨床研究有限公司 | Ｃｏｖｉｄ－１９新型コロナ肺炎を予防又は治療する医薬品、食品及びその使用 |
| MX2021005280A (es) * | 2021-05-04 | 2022-02-23 | Spv Timser S A P I De C V | Composicion farmaceutica que contiene triterpenoides pentaciclicos. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085800B2 (ja) * | 1986-12-19 | 1996-01-24 | エーザイ株式会社 | 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤 |
| JP2838720B2 (ja) * | 1989-10-31 | 1998-12-16 | ゼリア新薬工業株式会社 | 安定な点眼剤 |
| JP4056099B2 (ja) * | 1996-05-09 | 2008-03-05 | 森永乳業株式会社 | 水生動物の寄生生物性疾患の予防および治療剤 |
-
1997
- 1997-05-14 IT IT97MI001119A patent/IT1291366B1/it active IP Right Grant
-
1998
- 1998-05-06 EA EA199901024A patent/EA003126B1/ru not_active IP Right Cessation
- 1998-05-06 PL PL98336802A patent/PL189218B1/pl not_active IP Right Cessation
- 1998-05-06 IL IL13265198A patent/IL132651A0/xx active IP Right Grant
- 1998-05-06 JP JP54879998A patent/JP2001525814A/ja not_active Ceased
- 1998-05-06 CA CA002289550A patent/CA2289550A1/en not_active Abandoned
- 1998-05-06 US US09/423,611 patent/US6329339B1/en not_active Expired - Fee Related
- 1998-05-06 CN CN98805037A patent/CN1114447C/zh not_active Expired - Fee Related
- 1998-05-06 DK DK98925588T patent/DK0980254T3/da active
- 1998-05-06 WO PCT/EP1998/002797 patent/WO1998051334A1/en not_active Application Discontinuation
- 1998-05-06 GE GEAP19985126A patent/GEP20022672B/en unknown
- 1998-05-06 AU AU77646/98A patent/AU740944B2/en not_active Ceased
- 1998-05-06 KR KR1019997010372A patent/KR100592193B1/ko not_active Expired - Fee Related
- 1998-05-06 AT AT98925588T patent/ATE212232T1/de not_active IP Right Cessation
- 1998-05-06 HU HU0002985A patent/HU224956B1/hu not_active IP Right Cessation
- 1998-05-06 SK SK1544-99A patent/SK283584B6/sk not_active IP Right Cessation
- 1998-05-06 PT PT98925588T patent/PT980254E/pt unknown
- 1998-05-06 TR TR1999/02730T patent/TR199902730T2/xx unknown
- 1998-05-06 CZ CZ19993991A patent/CZ291932B6/cs not_active IP Right Cessation
- 1998-05-06 DE DE69803565T patent/DE69803565T2/de not_active Expired - Fee Related
- 1998-05-06 ES ES98925588T patent/ES2170501T3/es not_active Expired - Lifetime
- 1998-05-06 EP EP98925588A patent/EP0980254B1/en not_active Expired - Lifetime
- 1998-05-08 ZA ZA983917A patent/ZA983917B/xx unknown
- 1998-05-13 AR ARP980102218A patent/AR012849A1/es active IP Right Grant
- 1998-06-05 UA UA99126790A patent/UA63955C2/uk unknown
-
1999
- 1999-10-29 IL IL132651A patent/IL132651A/en not_active IP Right Cessation
- 1999-12-08 BG BG103968A patent/BG64748B1/bg unknown
-
2008
- 2008-12-25 JP JP2008331229A patent/JP2009102370A/ja not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012849A1 (es) | Composicion farmaceutica antivirica. | |
| CL2009002139A1 (es) | Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral. | |
| FI881305A7 (fi) | Ihmisen virusinfektioiden käsittely dsRNA:n ja virusinhibiittorien yhdistelmällä. | |
| ES2099158T3 (es) | Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo. | |
| DE10399032I1 (de) | Rekombinante Viren. | |
| DE58903472D1 (de) | Implantierbarer injektionskoerper. | |
| DE3852116D1 (de) | Herstellung von Proteinen in aktiver Form. | |
| ATE81978T1 (de) | Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen. | |
| DE3888086D1 (de) | Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine. | |
| DE59101182D1 (de) | Körpergewebeverträgliches Glas. | |
| DE69032207D1 (de) | Einführung von bakterien in ovo | |
| DE3885313D1 (de) | Peptide mit Laminin-Wirksamkeit. | |
| DE69110937D1 (de) | Herzschrittmacher zur Beendung von Herzarrhythmia. | |
| DE59007287D1 (de) | Polymerhaltige spinnpräparationen in form wässriger emulsionen oder wässriger lösungen. | |
| DK403384D0 (da) | Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf | |
| DE58905973D1 (de) | Einrichtung zur Abwehr von Vögeln. | |
| FI883005A7 (fi) | Promoottoreita vieras-DNA:n ilmaisemiseksi metylotrofisissa bakteereissa, niiden talteenotto ja niiden käyttö. | |
| DK36988A (da) | Ekspression af p.falciparum-circumsporozoitprotein af gaer | |
| FI880959A7 (fi) | Anvaendning av aktiverat rnas l som markeringsaemne i virusinfektioner. | |
| FI882741A7 (fi) | Rekombinantti-HTLV-III-proteiineja ja niiden käyttötapoja. | |
| PE43995A1 (es) | Procedimiento para la prevencion de la degradacion de la proteina c | |
| ES2024530B3 (es) | Programador de control de lavadora con microprocesador, y componente electromecanico. | |
| DE3869939D1 (de) | Biologisch wirksame peptide. | |
| NO862852L (no) | Klekkeapparat for pelagiske egg. | |
| DE59009060D1 (de) | Überexpression von Proteinen in rekombinanten Wirtszellen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |